North East and North Cumbria
ICS Formulary
ICS Formulary
2 Cardiovascular system
02-08-01 Low molecular weight heparins
| Enoxaparin Inhixa® |
|
Formulary
|
|
 Shared Care Guideline (CUMBRIA ONLY) - Low Molecular Weight Heparin (LMWH) - Enoxaparin |
|
Links
- Academic Health Science Network (North East and North Cumbria) - Atrial Fibrilation
- County Durham and Darlington DVT Pathway Information
- County Durham and Tees Valley Prescribing Guideline for the Use of Anticoagulants in Non-Valvular Atrial Fibrillation
- NICE NG148: Acute kidney injury: prevention, detection and management
- NICE NG158: Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
- NICE NG185: Acute coronary syndromes
- NICE NG191: COVID-19 rapid guideline: managing COVID-19
- NICE NG89: Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism
- North Cumbria - Anticoagulation Decision Support Tool
- North Cumbria - Cardiovascular workplan 2022
- North Cumbria anticoagulation guideline (2022)
- Shared Care Guideline (CUMBRIA ONLY) - Low Molecular Weight Heparin (LMWH) - Enoxaparin
- South Tees Hospitals Cardiology drug prescribing guidelines & formulary
Use of defibrotide in severe venoocclusive disease following stem cell transplant- Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
- Venous thromboembolic diseases: diagnosis, management and thrombophilia testing
- Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism